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a b s t r a c t
Background: In a previous clinical controlled trial (Lopes et al., 2014), narrative therapy (NT) showed
promising results in ameliorating depressive symptoms with comparable outcomes to cognitive-
behavioral therapy (CBT) when patients completed treatment. This paper aims to assess depressive
symptoms and interpersonal problems in this clinical sample at follow-up.
Methods: Using the Beck Depression Inventory-II and Outcome Questionnaire-45.2 Interpersonal
Relations Scale, naturalistic prospective follow-up assessment was conducted at 21 and 31 months after
the last treatment session.
Results: At follow-up, patients kept improving in terms of depressive symptoms and interpersonal
problems. The odds that a patient maintained recovery from depressive symptoms at follow-up were ﬁve
times higher than the odds that a patient maintained recovery from interpersonal problems. In the same
way, the odds of a patient never recovering from interpersonal problems were ﬁve times higher than the
odds of never recovering from depressive symptoms.
Limitations: The study did not control for the natural course of depression or treatment continuation.
Conclusions: For depressed patients with greater interpersonal disabilities, longer treatment plans and
alternative continuation treatments should be considered.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
The short-term effects of brief outpatient psychotherapy for uni-
polar depression have been widely reported in the psychotherapy
research literature over the past 60 years (e.g., Cuijpers et al., 2008a;
Demaat et al., 2007; Dobson, 1989; Elkin et al., 1989; Gloaguen et al.,
1998; Hansen et al., 2002; Hollon and Ponniah, 2010; Lambert and
Ogles, 2004). Cognitive-behavioral therapy (CBT) for depression and its
variants have also been well explored (Beck et al., 1979; Butler et al.,
2006; Cuijpers et al., 2008a, 2008b; Gibbons et al., 2010). Despite
effective treatments, approximately 20% of patients (Keller and Boland,
1998) or more (Barkow et al., 2003; Barnhofer et al., 2013) develop a
chronic form of the disorder for at least two years. Accordingly, Angst
(1992) found that 75% of patients had one or more recurrences of
depression at a 10-year follow-up. The chances of having another
depressive episode are approximately 50% higher for those who have
already had a ﬁrst major depressive episode (Hollon et al., 2002;
Judd et al., 1998). The more episodes one has experienced, the more
likely a patient is to experience reoccurrence or relapse. For
instance, chances for a fourth episode can reach 90% for those
who have already experienced three previous episodes (American
Psychiatric Association, 2000). Given the recurrence and chronicity
of MDD, long-term follow-ups should be considered to evaluate
treatment efﬁcacy (Chambless and Hollon, 1998; Cooper, 2008;
Lambert and Ogles, 2004; Shapiro et al., 1995).
In a comparative short-term controlled clinical trial, Lopes et al.
(2014) found that depressed patients who received narrative therapy
(NT) showed signiﬁcant reductions in depressive symptoms. The
authors concluded that those who completed NT or CBT had sig-
niﬁcantly superior outcomes when compared to a waiting list bench-
mark (Minami et al., 2007). The dropout rate was high (approx. 35%),
which led to less impressive results on the intend-to-treat analysis
compared with those who completed the treatment. A signiﬁcant
difference was found in depressive symptom reduction, which favored
CBT when all patients, dropouts and completers, were included in the
analysis. Despite this difference, no differences between treatments
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were found for interpersonal problems. Although almost half of all
patients fulﬁlled the criteria for clinical recovery by the end of
treatment (Jacobson and Truax, 1991), the rest remained unimproved.
The aim of this paper is to assess long-term outcomes of the patient
sample who have undergone either NT or CBT in the Lopes et al.
(2014) clinical trial, with special emphasis on the differential course of
depressive symptoms and interpersonal problems.
1.1. Long-term assessment of psychotherapy outcomes
There is vast evidence showing that psychotherapy relapse rates
for depression (mainly with CBT) are signiﬁcantly lower than
pharmacotherapy relapse rates (e.g., 56% against 26.5%, Demaat
et al., 2007; 60% against 29.5%, Gloaguen et al., 1998; 50% against
33%, Shea et al., 1992). However, there is a lack of evidence
comparing the differential long-term effects of different psycholo-
gical interventions (Cuijpers et al., 2008a). Although available
research suggests that different psychological treatments have
equivalent effects over time (Blay et al., 2002; e.g., Deffenbacher
et al., 1995; Shea et al., 1992), some evidence suggests the super-
iority of certain treatments (Ellison et al., 2009). For instance,
Shapiro et al. (1995) found equivalent post-treatment outcomes for
depression through CBT and psychodynamic-interpersonal psy-
chotherapy, but at the one year follow-up assessments, CBT showed
signiﬁcantly better outcomes. Given these inconsistent ﬁndings,
outcome follow-up assessments seem to be an essential part of
studies on the effectiveness of psychological treatments (Chambless
and Hollon, 1998; Cooper, 2008; Lambert and Ogles, 2004).
Evidence suggests that post-treatment scores predict follow-up
scores (Cooper, 2008; Nicholson and Berman, 1983; Robinson et al.,
1990), and some studies suggest a delayed response to treatment.
For instance, Anderson and Lambert (2001) found that among 102
patients, who were treated for diverse psychological problems, the
overall improvement rate increased from 39% at post-treatment to
53% at the six-month follow-up. Keller et al. (1992) also showed
that the probability of depression recovery was 70% two years after
discharge and increased up to 80% three years after discharge.
Accordingly, in research studying longer follow-up periods, recov-
ery rates increased from 20.4% at 15 years after discharge to 32.7%
at 25 years after discharge (Brodaty et al., 2001). Clinical gains are
thus expected in the follow-up assessments.
Despite ﬁndings that suggest some post-treatment improve-
ment, limited follow-up intervals are major limitations in most
long-term effect studies of psychotherapy; patients are often
assessed for no longer than a year after treatment (Cooper,
2008; Westen and Morrison, 2001). This trend of relatively short
follow-ups appears in a systematic review of 53 high-quality
comparative outcome studies examining psychotherapy for
depression (Cuijpers et al., 2008a). This study revealed a mean
follow-up period of 5.6 months (SD¼5.1, median¼four months),
and 93.4% of the studies only reported follow-up data for less than
12 months (only one study presented 24-month follow-up data).
To the authors' knowledge, the only study that evaluated the
follow-up effects of NT for depression (Vromans and Schweitzer,
2011) had a brief follow-up interval (of only three months).
Therefore, to better understand the long-term effects of psycho-
logical treatment, a longer follow-up period (more than one year)
is strongly recommended (Brodaty et al., 2001; Cooper, 2008;
Lambert and Ogles, 2004; Lambert, 2007).
1.2. Symptomatic vs. interpersonal change in depression
In daily practice, clinicians frequently observe that sympto-
matic change occurs faster than changes on interpersonal levels
(e.g., interpersonal problems, dysfunctional relationship patterns).
Accordingly, the phase model of change (Howard et al., 1993; Swift
et al., 2010) suggests that interpersonal improvements will take
longer to achieve when compared to symptomatic improvements.
Research examining brief treatments supports this observation.
For instance, Kopta et al. (1994) assessed clinically signiﬁcant
changes for different symptom clusters. The authors found that
for 50% of patients to recover from symptoms of acute distress, ﬁve
sessions were necessary. For the same 50% of patients to recover
from chronic distress, 14 sessions were necessary. For the char-
acterological symptoms cluster, which described interpersonal
problems, more than 104 sessions were required for 50% of
patients to recover, suggesting greater constancy of these pro-
blems. In another study, Barkham et al. (2002) assessed 105
moderately depressed patients who were assigned to three treat-
ment conditions with different therapy lengths, i.e., two-session,
eight-session and 16-session intervention conditions. Results
revealed that although many patients recovered from depressive
symptoms, signiﬁcantly fewer patients recovered from interper-
sonal problems in all conditions. Accordingly, a reanalysis of the
data from the Lopes et al. (2014) clinical trial found that more
patients have improved depressive symptoms than improved
interpersonal problems and that depressive symptom improve-
ment occurred signiﬁcantly faster than interpersonal problem
improvement during their brief psychological treatment of depres-
sion (Lopes et al., 2013). This ﬁnding suggests that time might be
an important factor in improving interpersonal problems.
None of the aforementioned studies showed evidence of the
long-term differential effects of different psychotherapies on
depressive symptoms and interpersonal problems (i.e., the phase
model). Thus, it is our goal to evaluate whether the differential
recovery from depressive symptoms and interpersonal problems is
maintained or reduced in a long-term evaluation and whether
these changes are different in CBT when compared to NT.
1.3. Research questions
The general purpose of this study is to evaluate the long-term
effects of NT and CBT in the aforementioned clinical trial (Lopes
et al., 2014) and to assess whether the two treatments differ in
stability over time. To address the aforementioned evidence gap,
speciﬁc research questions include the following: (1) Are ther-
apeutic gains maintained over time at 21- and 31-month follow-
ups, i.e., do patients keep improving, stabilize or relapse? (2) Do
changes in depressive symptoms differ from changes in interper-
sonal problems at long-term follow-ups? (3) Do any of these
effects (referred to in Questions 1 and 2) have differential out-
comes according to treatment modality (i.e., NT and CBT)?
2. Method
2.1. Participants
The sample in the original study (Lopes et al., 2014) comprised
63 patients diagnosed with major depressive disorder (MDD;
American Psychiatric Association, 2000) with moderate severity
at the onset of the study [Global Assessment of Functioning (GAF,
American Psychiatric Association, 2000): M¼59.84 (SD¼10.47)].
Some patients (20.6%) were included in the sample with second-
ary anxiety diagnoses or symptoms. Two patients (3%) had pre-
treatment scores in the functional range of the BDI-II, and seven
patients (11%) had scores in the functional range of the OQ-45.2 IR
subscale (Lopes et al., 2013). Patients were blindly assigned
according to their incoming order, alternating between NT
(n¼34) and CBT (n¼29). All baseline demographic and clinical
characteristics were equivalent for both groups. Patients were
on average 35.44 years old (SD¼11.51), and 81% were female.
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NT patients received on average 12.94 sessions (SD¼7.05), and
CBT patients received on average 14.90 sessions (SD¼6.48);
t(61)¼"1.13, p¼ .26 (this ﬁgure includes the dropouts).
Ten therapists participated in the study, along with two
experienced supervisors (one in NT and one in CBT). Mostly female
(70%), the therapists had on average 1.9 years of clinical experience
(SD¼2.13) and were on average 26 years old (SD¼4.2). They were
all psychologists and graduate students in the Clinical Psychology
Program (six at the master's level and four at the Ph.D. level). In
Portugal, psychologists complete a ﬁve-year program (master's
degree), including a one-year clinical internship, which is the
minimum training required for supervised practice. Reported
years of experience do not include this internship. The therapists
also received speciﬁc training on the relevant treatment manual
(for more information, see Lopes et al., 2014).
2.2. Treatment conditions
The CBT group followed the CBT treatment manual for depres-
sion, which is well described in the literature (Beck et al., 1979;
Leahy and Holland, 2000; Rush et al., 1977). The NT treatment
manual (Gonçalves and Bento, 2008) was developed speciﬁcally
for the clinical trial and is based on the work of Michael White
(White and Epston, 1990; White, 2007). In both conditions,
treatment was planned to be 20–60-minute sessions. Sessions 1–
16 were scheduled weekly, whereas sessions 17–20 were sched-
uled every other week. Overall, patients received on average 13.9
sessions (SD¼6.8), and the median was 16 sessions (Lopes et al.,
2013). Some patients terminated earlier, either agreeing with the
therapist that therapy goals had been achieved or through a
unilateral decision by the patient (dropout). Adherence to the
manual and therapist competence were monitored through
weekly supervisions (using session videotapes) and were assessed
from external judges' perspectives using a scale developed for this
purpose (Adherence and Competence Scale for Narrative and
Cognitive-Behavioral Therapy [ACS-N-CBT]; Gonçalves et al.,
2009), showing good results (Lopes et al., 2014).
Patient and therapist characteristics, therapist training, the two
treatment manuals and adherence and competence assessments are
described in detail in the original trial report (Lopes et al., 2014).
2.3. Measures
2.3.1. Beck depression inventory-II
The BDI-II (Beck et al., 1996) was used to measure depressive
symptoms, with a scale ranging from 0 (absence of depressive
symptoms) to 63 (severe depressive symptoms). It is considered
the gold standard for self-report measures that assess depression
for research purposes (Hatﬁeld and Ogles, 2004). The BDI-II has
shown a high internal consistency (α¼ .89 in the present ITT
sample and α¼ .91 in Steer et al., 2001). The measure has been
translated to and validated for Portuguese populations (Campos
and Gonçalves, 2011; Coelho et al., 2002). Because the Portuguese
studies did not calculate the reliable change index (RCI; Jacobson
and Truax, 1991), normative data gathered from a meta-analysis of
diverse samples (Seggar et al., 2002) were used to calculate the
proportion of clinical change (RCI, for improvement¼8.46; cut-off
score¼14.29).
2.3.2. Outcome questionnaire-45.2
The OQ-45.2 (Lambert et al., 1996a, 1996b) is a self-report
questionnaire designed to assess patients' progress throughout
therapy and its termination. It assesses not only psychological
distress but also interpersonal relations and the social role of the
patient. It comprises 45 self-report items rated on a ﬁve-point
scale (ranging from 0 to 4). The Cronbach's alpha was 93 in various
clinical samples (De Jong et al., 2007; Lambert et al., 1996a), and
similar reliability was obtained in our sample (α¼ .89), which
indicates excellent internal consistency. The current analysis used
the 11 self-report items of the interpersonal relations subscale
(OQ.45-IR, Lambert et al., 1996b), which aims to assess interper-
sonal complaints (e.g., loneliness, conﬂicts with others, family and
marriage problems and sexual concerns). This scale provides a
total score between 0 and 44, with higher scores indicating
interpersonal problems (Lambert et al., 1996b). Lambert et al.
(1996a) found good internal consistency (α¼ .74) and test-retest
reliability (r¼ .80). Umphress et al. (1997) reported good concur-
rent validity for the OQ-45.2 IR subscale. High correlations were
found between the OQ-45.2 IR and the Inventory of Interpersonal
Problems (IIP; Horowitz et al., 2000, 1988), a widely used measure
of interpersonal functioning. The RCI and the clinical cut-off score
(Jacobson and Truax, 1991) for the OQ-45.2 IR were calculated for
the Portuguese population (Machado and Fassnacht, 2014). Change
is considered reliable when a patient's score changes by at
least eight points, and scores above 14 points are considered
dysfunctional.
2.4. Procedures
All patients who took part in the clinical trial (Lopes et al.,
2014) were contacted for follow-ups no matter how many therapy
sessions they received or how treatment was terminated. The type
of termination was either a consentaneous decision between
therapist and patient (completers) or a unilateral decision by the
patient (dropouts). All patients were contacted by telephone. The
ﬁrst follow-up occurred an average of 21.3 months (SD¼7) after
therapy ended, and the second follow-up occurred an average of
31.3 months (SD¼9.1) after therapy ended. Phone calls were made
every two days at different times of the day for approximately one
month until the researcher had reached the patient. Patients'
research availabilities and questionnaire preferences (i.e., respond-
ing electronically, by post, or with a researcher's assistance) were
checked by phone. Those who were not reached by phone had
the invitation to participate and have the questionnaires sent via
e-mail or post.
2.5. Analysis
Chi-square analyses were used to determine whether return
rates (i.e., the percentage of questionnaires sent out that were
returned) differed by condition, therapy completion or treatment
response. Independent t-tests were used to assess pre-treatment
differences among conditions.
2.5.1. Analysis of continuous data
Random intercepts, random slopes, mixed growth curve mod-
els using time as a continuous variable (months after treatment
termination) and treatment condition as a between-subjects factor
were ﬁtted to compare depressive symptoms and interpersonal
problems across the two treatment conditions (NT to CBT) over
time. All models were ﬁtted using restricted maximum likelihood.
2.5.2. Clinical signiﬁcance analysis
Individual responses for both treatment conditions at 21- and
31-month follow-up observations were assessed with the main-
tenance of recovery, relapse at follow-up, recovery at follow-up and
maintenance of symptoms categories using Jacobson and Truax's
(1991) criteria, the most widely used method of assessing clinically
signiﬁcant change in psychotherapy research (Bauer et al., 2004;
Kendall et al., 2004; Ogles et al., 2001). Maintenance of recovery
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was assigned when a patient's follow-up scores remained below
the clinical cut-off in the range typical for a functional population
(i.e., 14.29 for BDI-II and 14 for OQ-45.2 IR). Relapse at follow-up
was assigned to patients who had recovered (i.e., attained clinical
signiﬁcant change) at termination and scored higher than the
clinical cut-off (i.e., in the range typical for a dysfunctional
population range) at follow-up assessments. Recovery at follow-up
was assigned to patients who had not recovered at post-treatment
but had recovered at follow-up assessments. Maintenance of symp-
toms was assigned to patients who had not recovered at post-
treatment neither at follow-up. Fisher's exact tests were used to
determine the between-group association of the clinical categories
providing two-tailed p-values (Preacher and Briggs, 2001).
2.5.3. Effect sizes
Effect sizes were expressed in odds ratios, which are widely
used in medical reports to “provide an estimate (with conﬁdence
interval) for the relationship between two binary variables” (Bland
and Altman, 2000, p. 1468). They are used as common indices to
compare recovery and relapse in the depressive symptom and
interpersonal problem domains.
3. Results
Fig. 1 describes the ﬂow of participants in the clinical trial: at
the 21-month follow-up observation, 35 patients were assessed
(10 were dropouts and 25 were completers); at the 31-month
follow-up observation, 42 patients were assessed (13 dropouts and
29 completers). Twenty-eight patients at the 21-month follow-up
and 21 patients at the 31-month follow-up were not reached by
the staff by any means. The time elapsed between treatment
termination and follow-up assessment did not differ between
treatment groups [21 months: t (33)¼1.34, p¼ .189; 31 months: t
(40)¼1.43, p¼ .160]. The reasons for attrition at follow-up were as
follows: participants did not reply (n¼11 at 21 months and n¼5 at
the 31 months) or had moved away and/or changed their phone
numbers (n¼4 at 21 months and at 31 months).
One “major problem with follow-up designs is that they are
particularly susceptible to bias resulting from differential reten-
tion” (Chambless and Hollon, 1998, p. 10). To ensure that the
present follow-up samples were comparable with the initial RCT
sample, possible bias due to differential retention was assessed.
3.1. Differential attrition
Overall return rates of 55.5% at the 21-month follow-up and
66.6% at the 31-month follow-up were achieved. A Pearson's chi-
square test revealed no return rate differences between the two
treatment conditions [59.9% for NT and 58.6% for CBT at 21
months, χ²(1, N¼63)¼ .20, p¼ .651; and 64.7% for NT and 69% for
CBT at 31 months, χ²(1, N¼63)¼ .13, p¼ .721]. There was also no
differential attrition according to recovery status; at 21 and 31
months, return rates for recovered patients were 63.6% and 81.8%,
respectively, and for non-recovered patients, 51.2% and 58.5%,
respectively [21-month follow-up: χ²(1, N¼63)¼ .89, p¼ .344; 31-
month follow-up: χ²(1, N¼63)¼3.49, p ¼ .062]. Return rates were
not higher among treatment completers when compared with
dropouts [21-month follow-up: 62.5% completers vs. 43.5% drop-
outs, χ²(1, N¼63)¼2.14, p¼ .144; 31-month follow-up: 72.5%
completers vs. 56.5% dropouts, χ²(1, N¼63)¼1.68, p¼ .195]. In
summary, these ﬁndings suggest that the retained follow-up
samples were not biased by differential return according to
treatment condition, therapy completion or treatment response.
3.2. Pre-treatment differences between NT and CBT
Although the two treatment groups did not show pre-treatment
differences in the original study (Lopes et al., 2013, 2014), the present
retained sample was re-analyzed to ensure that long-term ﬁndings at
follow-up would not be inadvertently confounded by pre-treatment
differences among conditions. Table 1 shows means and standard
deviation values for both measures at all time-points. Independent t-
tests revealed no signiﬁcant pre-treatment differences across condi-
tions based on initial severity [BDI-II: t (32)¼"1.942, p¼ .061; OQ-
45.2 IR: t (32)¼"1.027, p¼ .312], which supports the idea that this
sample is not obviously biased by pre-treatment differences.
3.3. Course of symptoms at follow-up and differences across
treatments
3.3.1. Analysis of continuous data
Using time as a continuous variable (months since treatment
termination) and treatment condition as a between-subjects
factor, the random intercepts, ﬁxed slopes1 mixed growth curve
model revealed a main effect of time on the BDI-II [F (1,89.82)¼
13.83, po .001] but no interaction effect of time and treatment
[F (1, 89.82)¼ .71, p¼ .402]. Thus, patients on average continued
reducing depressive symptoms at follow-ups, no matter their
treatment. An equivalent result was found on the OQ-54.2 IR.
There was a main effect of time [F (1,92.76)¼7.88, p¼ .006] but no
interaction effect of time and treatment [F (1,92,76)¼ .42, p¼ .521],
which indicated that patients on average continued reducing
interpersonal problems at follow-up observations, no matter their
treatment.
3.3.2. Clinical signiﬁcance
Patients' follow-up scores were examined to determine whether
the patient (a) maintained recovery at follow-up, (b) relapsed at
follow-up, (c) recovered at follow-up or (d) remained dysfunctional at
follow-up.
3.3.2.1. Course of depressive symptoms at follow-up. The course of
depressive symptoms (measured by BDI-II) from termination to
follow-ups is presented in Table 2.
In the NT condition, 22% (n¼4/18) of patients maintained
therapy gains at 21 months and 27% (n¼6/22) at 31 months after
therapy termination. In the CBT condition, 41% (n¼7/17) of
patients maintained therapy gains at 21 months and 30% (n¼6/
20) at 31 months after therapy termination. Comparing the two
conditions, no signiﬁcant differences were found (Fisher's exact
test: 21 months, p¼ .29; 31 months, n.s.).
A small proportion of patients experienced relapses at the 21-
month follow-up [NT¼6% (1/18) and CBT¼12% (2/17), p¼ .60] and at
the 31-month follow-up [NT¼5% (1/22) and CBT¼25% (5/20)]. A
substantial number of patients also remained depressed at the 21-
month [NT¼39% (7/18) and CBT¼18% (3/17), p¼ .26] and 31-month
follow-up assessments [NT¼41% (9/22) and CBT¼20% (4/20), p¼ .19].
An interesting ﬁnding is that 33% (6/18) of NT patients and 29%
(5/17) of CBT patients had not improved at post-treatment but did
recover after 21 months (i.e., 31% of the total sample). However, no
differences were found between the two treatment conditions (n.s.).
At the 31-month follow-up, this proportion of patients was main-
tained: 27% of the NT patients (6/22) and 25% of the CBT patients (5/
20) who had not recovered during treatment had recovered 31
months after treatment termination (i.e., 26%, of the total sample).
1 For both the BDI-II and the OQ-45.2 IR, random intercepts, ﬁxed slopes mixed
growth curve models were ﬁtted. However, the random slopes did not account for
any signiﬁcant variance in the models and are not reported here.
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3.3.2.2. Course of interpersonal problems at follow-up. The course of
interpersonal problems (measured by the OQ-45.2 IR) from termina-
tion to follow-ups is presented in Table 2. Again, no differences were
found between the two treatment conditions.
A small proportion of patients (11%; 4/35) had recovered
from interpersonal problems at post-treatment and maintained
recovery at the 21-month follow-up [NT¼5.5% (1/18); CBT¼18%
(3/17), p¼ .33]. At the 31-month follow-up, similar proportions of
patients (7%; 3/17) remained recovered [NT¼9% (2/22); CBT¼5%
(1/20), n.s.]. Only a small proportion of patients (9%; 3/35) who
had recovered at post-treatment relapsed at the 21-month follow-
up [NT¼11% (2/18); CBT¼6% (1/17), n.s.], whereas 18%
(4/42) experienced a relapse at the 31-month follow-up [NT¼9%
(2/22); CBT¼10% (2/20), p¼1]. On the other hand, a large propor-
tion of patients [21 months: NT¼78% (14/18); CBT¼53% (9/17),
p¼ .16; and 31 months: NT¼73% (16/22); CBT¼60% (12/20),
p¼ .52] were still considered interpersonally dysfunctional at the
follow-up.
3.4. Comparison of depressive symptoms and interpersonal problems
at follow-up
To compare recovery and relapse rates for depressive symp-
toms and interpersonal problems (Question 2), odds ratios
between recovery and relapse rates are reported (Table 3).
A small proportion of patients recovered from interpersonal
problems at post-treatment and maintained recovery at follow-up
[21 months¼11% (4/35); 31 months¼7% (3/42)]. Comparing this
ﬁnding to the proportion of patients who maintained recovery
from depressive symptoms at follow-up, signiﬁcant odds ratios
were obtained at both follow-up observations [21 months: BDI-
II¼31% (11/35), OQ-45.2 IR¼11% (4/35); odds ratio¼3.55, z¼1.97,
p¼ .049; 31 months: BDI-II¼29% (12/42); OQ-45.2 IR¼7% (3/42);
odds ratio¼5.20, z¼2.391, p¼ .016]. Thus, at the 21-month follow-
up, patients who had recovered at post-treatment were 3.55 times
more likely to maintain recovery from depressive symptoms than
from interpersonal problems; likewise, at the 31-month follow-up,
patients who had recovered at post-treatment were 5.20 times
more likely to maintain recovery from depressive symptoms than
from interpersonal problems.
Another signiﬁcant ﬁnding is the high proportion of patients
who had not recovered during treatment and remained dysfunc-
tional in terms of interpersonal problems [21 months¼66% (23/
35); 31 months¼66% (28/42)]. Comparing this ﬁnding with the
proportion of patients who had not recovered during treatment
and remained dysfunctional in terms of depressive symptoms [21
months: 29% (10/35); 31 months¼31% (13/42)], signiﬁcant odds
ratios were obtained at both follow-up observations. Hence, at
both follow-up observations, patients who had not recovered were
approximately ﬁve times more likely to remain dysfunctional in
Table 1
Means and standard deviations at pre-, post-treatment, 21- and 31-months follow-up observations, by treatment conditions.
Cognitive-behavioral therapy Narrative therapy Whole sample
M (SD) n M (SD) n M (SD) N
BDI-II
Pre-treatment 33.90 (11.47) 229 29.09 (9.63) 335 31.30 (10.70) 663
Post-treatment 18.90 (13.34) 229 22.59 (13.19) 335 20.89 (13.28) 663
21-Months follow-up 9.88 (7.83) 117 12.89 (10.09) 118 11.43 (9.06) 335
31-Months follow-up 13.45 (10.86) 220 13.50 (10.84) 222 13.48 (10.71) 442
OQ-45.2 IR
Pre-treatment 21.41 (5.79) 29 20.71 (5.76) 335 21.03 (5.74) 663
Post-treatment 18.07 (7.58) 229 19.15 (7.74) 335 18.65 (7.63) 663
21-Months follow-up 13.00 (7.52) 117 16.94 (6.69) 118 15.03 (7.28) 335
31-Months follow-up 13.80 (6.96) 220 15.86 (6.08) 222 14.88 (6.52) 442
Note: BDI-II¼Beck Depression Inventory; OQ-45.2 IR¼Outcome Questionnaire-45.2 Interpersonal Relations Subscale; NT¼Narrative Therapy; CBT¼Cognitive-Behavioral
Therapy. Pre- and post-treatment scores are also reported at Lopes et al. (2014).
Fig. 1. Flow diagram for the Lopes et al. (2014) clinical trial and follow-up assessments.
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terms of interpersonal problems when compared with depressive
symptoms (21 months: odds ratio¼ .20, z¼3.033, p¼ .0002; 31
months: odds ratio¼ .22, z¼3.199, p¼ .001).
To summarize the comparison between the symptomatic and
interpersonal domains, Fig. 2 shows the proportions of recovered
patients on the BDI-II and OQ-45.2 IR at post-treatment and at the
21- and 31-month follow-ups.
4. Discussion
The aim of this study was to prospectively evaluate a sample of
depressed patients who had previously received NT or CBT in a
controlled clinical trial (Lopes et al., 2014). In all analyses, allocation
to treatment group (i.e., NT or CBT) did not have signiﬁcant impact
on any of the variables studied. We should note that although CBT
appears to perform better at the clinically signiﬁcant evaluation at
follow-up, these ﬁndings merely represent trends, so no inferences
of CBT's superiority can be drawn from this dataset.
A case-by-case clinical signiﬁcance analysis of depressive symp-
toms reveals that one-third of all patients maintained treatment
gains at follow-up and few patients relapsed (approximately 10%).
Although almost half of the patients scored in the dysfunctional
range at follow-up (by either relapsing or never recovering), around
one-third of all patients did recover at follow-up. A multi-level
analysis conﬁrms this latter ﬁnding, showing that on average patients
Table 2
Proportion of patients remaining well or relapsing over 21 and 31 months follow-up assessments, by treatment group.
21 Months Follow-up (N¼35) Fisher's exact
probability
31 Months Follow-up (N¼42) Fisher's exact
probability
NT CBT NT CBT(n¼20)
(n¼18) (n¼17) (n¼22) (n¼20)
Depressive symptoms (according to BDI-II)
Recovereda after treatment and
maintainedb at follow-up
4 7 6 6
22% 41% .29 27% 30% n.s.
Recovered after treatment and
relapsedc at follow-up
1 2 1 5
6% 12% .60 5% 25% .09
Not recovered after treatment and
recovered at follow-up
6 5 6 5
33% 29% n.s. 27% 25% n.s.
Not recover after treatment and
maintained dysfunctional at follow-up
7 3 9 4
39% 18% .26 41% 20% .19
Interpersonal problems (according to OQ-45.2 IR)
Recovereda after treatment and
maintainedb at follow-up
1 3 2 1
5.5% 18% .33 9% 5% n.s.
Recovered after treatment and
relapsedc at follow-up
2 1 2 2
11% 6% n.s. 9% 10% n.s.
Not recovered after treatment and
recovered at follow-up
1 4 2 5
5.5% 23% .18 9% 25% .23
Not recover after treatment and
maintained dysfunctional at follow-up
14 9 16 12
78% 53% .16 73% 60% .52
Note: BDI-II¼Beck Depression Inventory; OQ-45.2 IR¼Outcome Questionnaire-45.2 Interpersonal Relations Subscale; NT¼Narrative Therapy; CBT¼Cognitive-Behavioral
Therapy. Percentages refer to patients with follow-up data.
a Jacobson and Truax (1991)'s clinical signiﬁcance criteria were used to establish whether a patient has recovered: reliable improvement (BDI-II improvement48.46;
OQ-45.2 IR improvement48) and decrease into the functional range (BDI-IIo14.29; OQ-45.2 IRo14).
b Maintenance of recovery: scores at follow-up assessments stayed in the functional range (BDI-IIo14.29; OQ-45.2 IRo14).
c Relapse: scores at follow-up assessments increased into the dysfunctional range (BDI-II414.29, OQ-45.2 IR414).
Table 3
Comparison of the proportion of patients remaining well or relapsing over 21 and 31 months follow-up assessments, according to BDI-II and OQ45-IR.
21 months Follow-up (N¼35) 31 Months follow-up (N¼42)
BDI-II OQ-45.2 IR Odds ratio 95% CI BDI-II OQ-45.2 IR Odds Ratio 95% CI
Recovereda after treatment and
maintainedb at follow-up
11 4 3.55 [1.00, 12.55]n 12 3 5.20 [1.34, 20.09]n
31% 11% 29% 7%
Recovered after treatment and
relapsedc at follow-up
3 3 1.00 [.18, 5.33] 6 4 1.58 [.41, 6.08]
9% 9% 14% 10%
Not recovered after treatment and
recovered at follow-up
11 5 2.75 [.84, 8.99]dagger;† 11 7 1.77 [.61, 5.14]
31% 14% 26% 17%
Not recover after treatment and
maintained dysfunctional at follow-up
10 23 .20 [.08, .57]nn 13 28 .22 [.09, .56]nn
29% 66% 31% 66%
Note: BDI-II¼Beck Depression Inventory; OQ-45.2 IR¼Outcome Questionnaire-45.2 Interpersonal Relations Subscale. Percentages refer to patients with follow-up data.
a Jacobson and Truax (1991)'s clinical signiﬁcance criteria were used to establish whether a patient has recovered: reliable improvement (BDI-II improvement48.46;
OQ-45.2 IR improvement48) and decrease into the functional range (BDI-IIo14.29; OQ-45.2 IRo14).
b Maintenance of recovery: scores at follow-up assessments stayed in the functional range (BDI-IIo14.29; OQ-45.2 IRo14).
c Relapse: Scores at follow-up assessments increased into the dysfunctional range (BDI-II414.29; OQ-45.2 IRo14).
n po .05.
nn po .01.
† po .10.
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continued ameliorating depressive symptoms and interpersonal
problems from treatment termination through the 21- and
31-month follow-up observations. The continuing improvement over
time may corroborate the argument that psychotherapy, unlike
psychopharmacological interventions, will improve actual symptoms
and help patients to develop strategies to cope with the underlying
mechanisms that are responsible for lasting depressive symptoms
(Beck et al., 1979; Chambless and Hollon, 1998; DeRubeis et al., 2005;
Hollon et al., 2005). Similarly, our study's recovery rate for depressive
symptoms at follow-up (approximately one-third) was superior to
that of earlier studies. For instance, Keller et al. (1992) observed a 21%
recovery rate at a 24-month follow-up.
Notably, even in a long-term evaluation, interpersonal pro-
blems still seem to be much more resistant to change than
depressive symptoms. Only approximately 10% of patients keep
their interpersonal gains at follow-up, and only approximately 15%
of patients who did not recover in interpersonal domain during
treatment did recover by the follow-up observation. At the same
time, a large proportion of patients (approximately 66%) still
reported interpersonal problems (i.e., with scores in the dysfunc-
tional range) at follow-up. This ﬁnding is in line with the post-
treatment outcomes of this very sample (Lopes et al., 2013), with
the phase model (Howard et al., 1993; Swift et al., 2010) and with
previous research comparing the course of depressive symptoms
and interpersonal problems during and after treatment (Barkham
et al., 2002, 1993, 1996; Hilsenroth et al., 2001; Kopta et al., 1994;
Vromans and Schweitzer, 2011).
Unfortunately, interpersonal impairment is highly associated with
depression (Hammen and Brennan, 2002; Hecht et al., 2005; McEvoy
et al., 2013). Still, it was not within the scope of this study to address
the relationships between the symptomatic and interpersonal
domains; this study instead sought to conﬁrm the stability of the
interpersonal domain when compared with the symptomatic domain.
In future research, it is crucial to better understand the possible causal
relationships between interpersonal malfunctioning and depression.
4.1. Limitations
Although follow-up studies are an important part of psychotherapy
outcome research, they are hard to conduct and difﬁcult to interpret
(Chambless and Hollon, 1998). In general, it is hard to know
what interferes with patient progress in psychotherapy research; in
long-term follow-up evaluations, this problem is even more salient.
Keeping this limitation in mind, the results presented here are not
intended to prove any cause-effect relationship between psychother-
apy treatment and clinical outcomes after 21 or 31 months because
the study did not control for spontaneous remission, the natural
course of depression or treatment continuation during the follow-up
period (e.g., medication or alternative treatments, including psy-
chotherapy). Another confounding variable might be the chronicity
of the depressive symptoms; e.g., acutely and chronically depressed
patients were not analyzed separately in the present study. As Keller
and Shapiro (1982) showed, outcomes for patients with chronic
depression are clearly different from those who have a single acute
episode. This difference could be an important issue to consider in
future studies.
Another limitation of this study involves the assessment
method. The available data did not allow pinpointing when the
patient relapsed. Future follow-up designs should employ a more
regular assessment schedule (Chambless and Hollon, 1998).
4.2. Strengths
As the preliminary analysis shows, the retained sample for
long-term follow-up is representative of the original treatment
sample. These ﬁndings are also not biased by low or differential
returns (according to treatment condition, treatment completion
and treatment response) or pre-treatment differences among
conditions.
Another study strength is the relatively long follow-up period,
which is longer than the average period observed in the literature.
Moreover, the present return rates are similar to those of other reports
in psychotherapy research with shorter follow-up periods (Barkham
et al., 1999; Snell et al., 2001; e.g., Vromans and Schweitzer, 2011). In
addition, studies rarely compare the differential long-term efﬁcacy of
psychotherapy models. Furthermore, it is recommended that “the
length of the follow-up required is likely to depend on the natural
course of the disorder in question and the strength and stability of the
treatment effect that is worthy of detection” (Chambless and Hollon,
1998, p. 10). As a cornerstone of studies examining the natural course
of depression, the Collaborative Depression Study (CDS; Katz and
Klerman, 1979) found that by the second year of follow-up, 20% of
patients remained ill (Keller et al., 1982). The same sample of patients
was assessed three years later (a ﬁve-year follow-up), and only 12% of
Fig. 2. Proportions of patients recovering from depressive symptoms and interpersonal problems at post-treatment and follow-ups.
Note: BDI-II = Beck Depression Inventory, OQ-45.2 IR = Outcome Questionnaire-45.2 Interpersonal Relations Subscale. **p o .01.
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patients remained ill (Keller et al., 1992). Subsequent follow-ups at 10
(Mueller et al., 1996) and 15 years (Keller and Boland, 1998) found that
7% and 6% of patients, respectively, were still ill. This pattern suggests
that recovery rates tend to be greater in the ﬁrst few years of follow-
up and thereafter stabilize. An almost three-year follow-up period
thus seems to be a reasonable time period to describe the course of
the disease in a depressed sample.
Finally, it has been mentioned that “psychiatric research
emphasizes case-categorization methods designed to identify
putatively discrete episodes of disorder, whereas the psychological
approach relies solely on parametric analysis of means and
continuously distributed scores” (Shapiro et al., 1995, p. 379).
Using stringent deﬁnitions of recovery and relapse (Jacobson and
Truax, 1991) may have provided more conﬁdence in the results.
Using such a method considers values from large samples of
clinical and community data to establish norms for functional
and dysfunctional ranges. In addition, a multi-level analytical
approach was used to conﬁrm the results of the clinical analyses.
4.3. Implications of the study
From a clinical perspective, the fact that one-third of the
patients never recover from depressive symptoms is alarming. It
is recommended that clinical practitioners follow patients who
were treated for depression for a signiﬁcant period of time, as a
substantial proportion of them will relapse within the following
two years. Follow-up sessions addressing red ﬂags that might
precipitate relapse would also be a ﬁrst option. Clinicians should
also consider longer treatment plans for patients with longer
histories of depression. Fava et al. (1998)showed that a consider-
ably greater proportion of patients remained symptom-free
(approximately 75%) after two years with a CBT maintenance
intervention compared with regular clinical management (less
than 20%). Relapse prevention approaches, such as mindfulness-
based cognitive therapy (Bondolﬁ et al., 2010; Piet and Hougaard,
2011; Teasdale et al., 2000) and cognitive therapy (e.g., Bockting
et al., 2005, 2009), are thus empirically supported continuing
treatments for decreasing relapse rates.
The present ﬁndings highlight the lack of change in interper-
sonal problems, which showed lower recovery rates than depres-
sive symptoms. Interpersonal therapy (IPT) has been proven to be
efﬁcacious for continuation and maintenance therapy, at least at
more than monthly “doses” (Hollon et al., 2002). Patients given
continuation IPT showed improved social functioning over time,
although this effect did not emerge until 8–10 months of treat-
ment continuation (Frank and Spanier, 1995; Hollon et al., 2002;
Weissman et al., 1974). Hence, alternative continuation treatments
should be sought for patients with greater interpersonal disabilities.
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